David B. Feirstein - Partner


David B. Feirstein david.feirstein@kirkland.com Download V-Card New York Phone: +1 212-446-4861 Fax: +1 212-446-4900 Corporate Corporate Governance & Counseling Mergers & Acquisitions New York New York University School of Law, J.D., 2005 magna cum laude Order of the Coif NYU Journal of Law and Business, Founding Board Member and Projects Editor University of Pennsylvania, B.A., Political Science, 2000	11/29/2012 Financial Times \| Awards & Rankings U.S. Innovative Lawyers Report 6/29/2012 The New York Times Dealbook \| Press Mentions Bristol-Myers in Deal for Amylin Valued at $7 Billion Kirkland represents Bristol-Myers Squibb Company in its agreement announced to acquire Amylin Pharmaceuticals for a total transaction value of approximately $7 billion. 4/3/2012 New York Times Dealbook \| Press Mentions Burger King to Return to Public Markets Kirkland represents Burger King Worldwide Holdings, Inc. and 3G Capital in Burger King's definitive business combination agreement with Justice Holdings Limited, a publicly listed UK investment vehicle. 1/9/2012 The Am Law Daily \| Press Mentions Kirkland, Dechert Advise as Bristol-Myers Squibb Acquires Inhibitex for $2.5 Billion Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc. 9/15/2011 Kirkland & Ellis LLP \| Press Releases Kirkland & Ellis LLP Appoints New Partners